Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study

Autor: Pons-Tostivint, E., Daubisse-Marliac, L., Grosclaude, P., Oum sack, E., Goddard, J., Morel, C., Dunet, C., Sibrac, L., Lagadic, C., Bauvin, E., Bergé, Y., Bernard-Marty, C., Vaysse, C., Lacaze, J.L.L.

Publikováno v: In The Breast August 2019 46:170-177

Métastases cérébrales de cancer du sein : traitements systémiques

Autor: Taillibert, S., Conforti, R., Bonneterre, J., Bachelot, T., Le Rhun, E., Bernard-Marty, C.

Publikováno v: In Cancer / Radiothérapie February 2015 19(1):36-42

A significant proportion of elderly patients develop hormone-dependant “luminal-B” tumours associated with aggressive characteristics

Autor: Durbecq, V., Ameye, L., Veys, I., Paesmans, M., Desmedt, C., Sirtaine, N., Sotiriou, C., Bernard-Marty, C., Nogaret, J.M., Piccart, M., Larsimont, D.

Publikováno v: In Critical Reviews in Oncology and Hematology 2008 67(1):80-92

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

Autor: Gancberg, D., Di Leo, A., Cardoso, F., Rouas, G., Pedrocchi, M., Paesmans, M., Verhest, A., Bernard-Marty, C., Piccart, M.J., Larsimont, D. ^*

Publikováno v: In Annals of Oncology July 2002 13(7):1036-1043

Model-Based Quantification of Impact of Genetic Polymorphisms and Co-Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast Cancer.

Autor: Puszkiel A; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France., Arellano C; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France., Vachoux C; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France., Evrard A; Laboratoire de Biochimie et Biologie Moléculaire, Centre Hospitalier Universitaire Nîmes-Carémeau, Nîmes, France.; IRCM, Inserm, Université de Montpellier, ICM, Montpellier, France., Le Morvan V; Inserm U1218, Université de Bordeaux, Bordeaux, France.; Institut Bergonié, Bordeaux, France., Boyer JC; Laboratoire de Biochimie et Biologie Moléculaire, Centre Hospitalier Universitaire Nîmes-Carémeau, Nîmes, France., Robert J; Inserm U1218, Université de Bordeaux, Bordeaux, France.; Institut Bergonié, Bordeaux, France., Delmas C; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France.; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., Dalenc F; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France.; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., Debled M; Institut Bergonié, Bordeaux, France., Venat-Bouvet L; Centre Hospitalier Universitaire Dupuytren, Limoges, France., Jacot W; Institut du Cancer de Montpellier, Montpellier, France., Dohollou N; Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France., Bernard-Marty C; Clinique Pasteur - ONCORAD, Toulouse, France., Laharie-Mineur H; Clinique Tivoli-Ducos, Bordeaux, France., Filleron T; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., Roché H; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., Chatelut E; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France.; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., Thomas F; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France.; Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France., White-Koning M; Cancer Research Center of Toulouse (CRCT), Inserm U1037, Université Paul Sabatier, Toulouse, France.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 May; Vol. 109 (5), pp. 1244-1255. Date of Electronic Publication: 2020 Nov 10.